Invention Grant
- Patent Title: Anti-CD47 antibodies and uses thereof
-
Application No.: US16473867Application Date: 2018-08-28
-
Publication No.: US11292836B2Publication Date: 2022-04-05
- Inventor: Andy Tsun , Dandan Liu , Bingliang Chen , Junjian Liu
- Applicant: INNOVENT BIOLOGICS (SUZHOU) CO., LTD.
- Applicant Address: CN Jiangsu
- Assignee: INNOVENT BIOLOGICS (SUZHOU) CO., LTD.
- Current Assignee: INNOVENT BIOLOGICS (SUZHOU) CO., LTD.
- Current Assignee Address: CN Jiangsu
- Agency: Leason Ellis, LLP
- Priority: CN201710759828.9 20170829
- International Application: PCT/CN2018/102752 WO 20180828
- International Announcement: WO2019/042285 WO 20190307
- Main IPC: A61K39/00
- IPC: A61K39/00 ; G01N33/53 ; C07H21/04 ; C12P21/06 ; C12N15/87 ; C12N15/74 ; C07K16/00 ; C07K16/46 ; C07K16/28 ; A61P35/00 ; G01N33/577
Abstract:
The present invention is directed to a novel antibody against CD47 and the antibody fragments thereof and a composition comprising the antibody or antibody fragments thereof. The present invention relates further to a nucleic acid encoding the antibodies or antibody fragments thereof and host cells comprise the same, as well as the relevant use of the same. In addition, the present invention is also directed to the use of these antibodies and antibody fragments in the therapy and diagnosis.
Public/Granted literature
- US20200181259A1 ANTI-CD47 ANTIBODIES AND USES THEREOF Public/Granted day:2020-06-11
Information query
